Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Study ID: NCT06235801
Start Date: 2024-05-22
End Date: 2029-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Gilteritinib

Momelotinib

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Study ID: NCT06351631
Start Date: 2024-05-23
End Date: 2034-12-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

Bomedemstat

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Phase IB/II of CPX-351 for Relapse Prevention in AML

Study ID: NCT04990102
Start Date: 2023-05-22
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

CPX-351

Sponsor

Georgetown University

Source: clinicaltrials.gov

Share:
Add to list

Exercise Prehabilitation for Locoregional Esophageal Cancer

Study ID: NCT06430346
Start Date: 2024-05-21
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Exercise

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Study ID: NCT06051942
Start Date: 2022-11-22
End Date: 2026-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

125

Intervention / Treatment

Robotic Waterjet Treatment

Sponsor

PROCEPT BioRobotics

Source: clinicaltrials.gov

Share:
Add to list

A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

Study ID: NCT05200442
Start Date: 2022-08-22
End Date: 2027-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

53

Intervention / Treatment

VS-6766/avutometinib

Cetuximab

Pill Diary

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Study ID: NCT05104983
Start Date: 2021-10-13
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

64

Intervention / Treatment

Sirolimus

Placebo

Sponsor

Darcy Krueger

Source: clinicaltrials.gov

Share:
Add to list

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Study ID: NCT06959641
Start Date: 2025-06-06
End Date: 2030-09-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

33

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Survey Administration

X-Ray Imaging

Zanzalintinib

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Study ID: NCT05705531
Start Date: 2023-08-18
End Date: 2028-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

230

Intervention / Treatment

Biospecimen Collection

Electronic Health Record Review

Magnetic Resonance Imaging

Survey Administration

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Study ID: NCT01853631
Start Date: 2014-02
End Date: 2036-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

64

Intervention / Treatment

Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells

Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list